Respiratory
Over the last 15 years I have developed a research interest into non-CF Bronchiectasis. This focused primarily on primary ciliary dyskinesia. I developed a new method for the evaluation of function of the microscopic hairs (cilia) which line the airways of the lung. This has been standardized and now used as an accepted method for the diagnosis of primary ciliary dyskinesia and research platform.
Cystic Fibrosis
Cystic Fibrosis (CF) research is another significant research area. I am the PI on several clinical trials looking at new medications in CF patients.
I coordinate the CF clinic multidisciplinary research program and this is promoting research into nursing, physiotherapy, pharmacy and dietetic issues within CF. Current themes are transitional care to adulthood; physiotherapy interventions; location of CF care and outcome in adolescence and adherence to medication. We work closely with the adult CF clinic at St. Paul's on several joint projects.
Current Projects
Evalaution of a transitional pathway in CF care
This is a rewtrospective analysis of an quality improvement project to inpmprove health care in CF youth.
Current Projects
Adherence to therapy in CF patients
Co PI:
Self funded.
Evalaution of adherance therapy in CF patients. ldentifying bariers to adherance wuithin BC. This is a joint project with St Pauls.
Current Projects
Establishment of Digitial high speed video in the diagnosis of primary ciliary dyskinesia in BC.
Principal investigator for this trial
Funded: Telethon
Telethon Award 2009
Jacob Gravelle, Undergraduate Volunteer:Undergraduate Student
Jung-Bahadur Kandola, Co-op student
Alam Lakhani, Research Manager
Vanessa McMahon, Nurse Clinician
Nazifaa Vasaya, Research Coordinator
James Zlosnik, Research Associate - Chronic Bacterial Infections in Cystic Fibrosis.
Primary Scientist and Manager - Canadian Burkholderia Cepacia Complex research
Referral Repository.
Project Manager - Centre for Understanding and Preventing Infection in Children. , Research Associate - Chronic Bacterial Infections in Cystic Fibrosis.
Primary Scientist and Manager - Canadian Burkholderia Cepacia Complex research
Referral Repository.
Project Manager - Centre for Understanding and Preventing Infection in Children.
Human DNA testing could improve outcomes for patients with COVID-19.
That’s the key idea put forth in preliminary research posted this month to bioRxiv that highlights the potential benefits of testing COVID-19 patients for genetic variants of ACE2—the protein identified as the point-of-entry for the SARS-COV-2 virus into human cells.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.